Sex-specific risks for pediatric onset among patients with Crohn's disease

Scott M Montgomery1, Andrew J Wakefield, Anders Ekbom

  • 1Clinical Epidemiology Unit, Department of Medicine, Karolinska Hospital M9:01, Karolinska Institutet, SE-171 76 Stockholm, Sweden. Scott.Montgomery@medks.ki.se

Insights

Maternal age at pregnancy is linked to pediatric Crohn's disease risk in females. Older mothers increase the risk for female children developing Crohn's disease (pediatric onset).

Area of Science:

  • Gastroenterology
  • Pediatric Gastroenterology
  • Epidemiology

Background:

  • Increasing incidence of pediatric Crohn's disease (CD) may stem from broader incidence increases or improved diagnostics.
  • Potential etiologic differences exist between adult and pediatric CD, possibly with varying risks and sex-specific susceptibilities.
  • Sex ratio differences in adult vs. pediatric CD suggest underlying etiologic variations.

Purpose of the Study:

  • To investigate if factors like sibling number and maternal age, known for overall CD risk, are associated with pediatric-onset CD.
  • To determine if these associations differ between pediatric and adult-onset CD.
  • To explore sex-specific differences in the association between risk factors and pediatric CD onset.

Main Methods:

  • A nested case-control study design was employed.
  • Data from the Swedish Inpatient Register for patients born between 1960 and 1998 were analyzed.
  • 4826 patients with Crohn's disease were included, with 46.6% being male.

Main Results:

  • A significant association was found between maternal age at pregnancy and pediatric Crohn's disease, specifically in females.
  • Female patients whose mothers were older at pregnancy showed a progressively higher risk of pediatric CD.
  • No significant associations were observed for paternal age or the number of siblings.

Conclusions:

  • Females may exhibit increased susceptibility to factors linked to advanced maternal age, elevating their risk for pediatric-onset Crohn's disease.
  • Older maternal age during pregnancy is a potential risk factor for developing Crohn's disease in female children.
Abstract

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...